Lou Y - Search Results

1

MitraClip for the treatment of heart failure with mitral regurgitation: A cost-effectiveness analysis in a Chinese setting.

Xia W, Han K, Lou Y. Xia W, et al. Among authors: lou y. Front Cardiovasc Med. 2022 Nov 11;9:970118. doi: 10.3389/fcvm.2022.970118. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36440042 Free PMC article.

2

Efficacy and Safety of Transcatheter vs. Surgical Aortic Valve Replacement in Low-to-Intermediate-Risk Patients: A Meta-Analysis.

Lou Y, Gao Y, Yu Y, Li Y, Xi Z, Swe KNC, Zhou Y, Nie X, Liu W. Lou Y, et al. Front Cardiovasc Med. 2020 Nov 16;7:590975. doi: 10.3389/fcvm.2020.590975. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 33304932 Free PMC article.

3

Economic Evaluation of Transcatheter Aortic Valve Replacement Compared to Surgical Aortic Valve Replacement in Chinese Intermediate-Risk Patients.

Zhang W, Lou Y, Liu Y, Wang H, Zhang C, Qian L. Zhang W, et al. Among authors: lou y. Front Cardiovasc Med. 2022 May 26;9:896062. doi: 10.3389/fcvm.2022.896062. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35722099 Free PMC article.

4

Sacubitril-valsartan for the treatment of hypertension in China: A cost-utility analysis based on meta-analysis of randomized controlled trials.

Lou Y, Yu Y, Liu J, Huang J. Lou Y, et al. Front Public Health. 2022 Aug 17;10:959139. doi: 10.3389/fpubh.2022.959139. eCollection 2022. Front Public Health. 2022. PMID: 36062091 Free PMC article.

5

Cost-Effectiveness of Adding Empagliflozin to Standard Treatment for Heart Failure with Preserved Ejection Fraction Patients in China.

Lou Y, Hu T, Huang J. Lou Y, et al. Am J Cardiovasc Drugs. 2023 Jan;23(1):47-57. doi: 10.1007/s40256-022-00550-9. Epub 2022 Oct 8. Am J Cardiovasc Drugs. 2023. PMID: 36207658

6

Sacubitril-valsartan versus enalapril for the treatment of acute decompensated heart failure in Chinese settings: A cost-effectiveness analysis.

Hu T, Liu Y, Lou Y. Hu T, et al. Among authors: lou y. Front Pharmacol. 2023 Mar 2;14:925375. doi: 10.3389/fphar.2023.925375. eCollection 2023. Front Pharmacol. 2023. PMID: 36937882 Free PMC article.

7

Sacubitril/Valsartan for Heart Failure with Preserved Ejection Fraction: A Cost-Effectiveness Analysis from the Perspective of the Chinese Healthcare System.

Wang Z, Lou Y, Wang Q, Sun M, Li X, Wang Y, Wang Y. Wang Z, et al. Among authors: lou y. Clin Drug Investig. 2023 Apr;43(4):265-275. doi: 10.1007/s40261-023-01249-8. Epub 2023 Mar 28. Clin Drug Investig. 2023. PMID: 36976423

8

Endovascular treatment for basilar artery occlusion: a cost-effectiveness analysis based on a meta-analysis.

Wang L, Yu Y, Zhou L, Xu P, Guo X, Xie Y, Cai J, Pan M, Tang J, Gong Q, Su R, Lou Y, Liu Y. Wang L, et al. Among authors: lou y. Front Neurol. 2023 Oct 20;14:1267554. doi: 10.3389/fneur.2023.1267554. eCollection 2023. Front Neurol. 2023. PMID: 37928158 Free PMC article.

9

Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure with a Preserved Ejection Fraction: A Meta-Analysis of Randomized Controlled Trials.

Lou Y, Yang Q, Zhang W, Yu Y, Huang J. Lou Y, et al. Rev Cardiovasc Med. 2022 Oct 31;23(11):374. doi: 10.31083/j.rcm2311374. eCollection 2022 Nov. Rev Cardiovasc Med. 2022. PMID: 39076185 Free PMC article.

10

The Effects of Continuous Positive Airway Pressure Therapy for Secondary Cardiovascular Prevention in Patients with Obstructive Sleep Apnoea: A Systematic Review and Meta-Analysis.

Li H, Pan Y, Lou Y, Zhang Y, Yin L, Sanderson JE, Fang F. Li H, et al. Among authors: lou y. Rev Cardiovasc Med. 2022 May 27;23(6):195. doi: 10.31083/j.rcm2306195. eCollection 2022 Jun. Rev Cardiovasc Med. 2022. PMID: 39077164 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,665 results

Search Page

Filters